 |
 |
| |
EBD Group is the leading partnering firm for
the global life science industry. Since its
inception in 1993, EBD Group's mission has been
to facilitate the biotech-pharma partnerships
that deliver tomorrow's healthcare treatments
to patients worldwide. 
|
|
|
 |
|
|
|
| The EBD Group family
of partnering events constitutes the
largest dedicated partnering platform in the world.
More companies, more delegates, more deals.
Find the next opportunity to join this connected,
dealmaking community. |
| |
| |
BioPharm America™ 2014
September 22–24, 2014 • Boston, MA, USA
http://www.ebdgroup.com/bpa
EBD Group's North American equivalent of its European partnering conferences.
Global Impact Forum™ 2014
October 8–9, 2014 • Zurich, Switzerland
www.globalimpactforum.com/
Global Impact Forum™ is a unique partnering conference to facilitate transactions in social investing and philanthropy through one-to-one meetings. Global Impact Forum provides an innovative forum to partner, identify and generate investment and funding opportunities.
BIO-Europe® 2014
November 3–5, 2014 • Frankfurt, Germany
www.ebdgroup.com/bioeurope
BIO-Europe is Europe’s largest partnering conference, serving the global biotechnology industry. The conference annually attracts international leaders from biotech, pharma and finance along with the most promising start-ups and emerging companies. It is the “must attend” event for getting business done in the biotech industry.
|
All upcoming conferences
|
|
|
|
|
|
| |
|
|
| |
|
| partnering360® is your online access to the people, events, and information essential for partnering success. |
| |
|
|
|
|
|
| |
|
|
| |
|
 |
| The most advanced, intuitive software
for finding and connecting with potential
partners. |
| |
|
|
|
|
|
| |
|
|
| |
|
|
|
 |
|
Deal trends in Regenerative Medicine
The field of regenerative medicine is an up-and-coming new approach for targeting and treating diseases, involving the repair and restoration...
Market Update: Cancer Immunotherapy
Perhaps no other recent topic in oncology has generate as much excitement as the immunotherapies. PD-1s, checkpoint inhibitors, CAR-T, and DC...
Visit partnering360:Insight »
Announcement Service
Receive news on this and other EBD Group conferences.
Please, enter a valid email address
To complete your subscription, click the confirmation link in the email you will receive from us shortly
|
|
|
 |
|
